Parasites Transmitted by Blood Transfusion

  • L. M. Kortbeek
  • E. Pinelli
Part of the Developments in Hematology and Immunology book series (DIHI, volume 37)


Transmission of parasites by blood transfusion is considered to be an important issue especially with regard to global travel and land development that can alter the habitats of disease carrying insects and animals [1]. Different to viruses and bacteria, parasites have complicated life cycles that include different parasitic stages invading various tissues and in most cases an intermediate host is involved. Human parasitic infections are often asymptomatic or can develop into chronic diseases. This is probably one of the reasons why less attention has been given to infection with these pathogens. However, acute disease and major complication due to infection with parasites are commonly observed in immuno-compromised patients including, cancer, transplantation and HIV patients. Others that are also at risk in developing disease are less immuno-competent persons including children, elderly, undernourished and those suffering from other diseases at the time of infection.


Visceral Leishmaniasis Cutaneous Leishmaniasis Congenital Toxoplasmosis Toxoplasma Infection Plasmodium Malariae 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Chamberland ME. Emerging Infectious Agents: Do They Pose a Risk to the Safety of Transfused Blood and Blood Products? Clin.Infect.Dis. 2002; 34: 797–805.PubMedCrossRefGoogle Scholar
  2. 2.
    Malaria and babesia. Garcia LS, Bruckner DA III, ASM. Diagnostic Medical Parasitology. Washington DC, 1997: 135–66. Ref Type: Serial ( Book, Monograph).Google Scholar
  3. 3.
    Malaria. Chin J. 17, APHA. Control of communicable diseases. Washington DC. 2002: 310–23. Ref Type: Serial ( Book, Monograph).Google Scholar
  4. 4.
    Baird JK, Wiady I, Fryauff DJ, et al. In Vivo Resistance to Chloroquine by Plasmodium Vivax and Plasmodium Falciparum at Nabire, Irian Jaya, Indonesia. Am J Trop Med Hyg 1997; 56: 627–31.Google Scholar
  5. 5.
    Mungai M, Tegtmeier G, Chamberland M, Parise M. Transfusion-Trans mitted Malaria in the United States From 1963 Through 1999. N Engl J Med 2001; 344: 1973–78.Google Scholar
  6. 6.
    MacArthur JR. Malaria Surveillance-United States, 1997. MMWR 50(SS01) 2001: 25–44. Ref Type: Generic.Google Scholar
  7. 7.
    Sabatinelli G, Ejov M, Joergensen P. Malaria in the WHO European Region (1971–1999). Euro Surveill 2001; 6: 61–65.PubMedGoogle Scholar
  8. 8.
    Silvie O, Thellier M, Rosenheim M, et al. Potential Value of Plasmodium Falciparum-Associated Antigen and Antibody Detection for Screening of 9 lood Donors to Prevent Transfusion- Transmitted Malaria. Transfusion 2002; 42: 357–62.PubMedCrossRefGoogle Scholar
  9. 9.
    Dodd RY. Transmission of Parasites by Blood Transfusion. Vox Sang. 1998; 74 (Suppl 2): 161–63.PubMedCrossRefGoogle Scholar
  10. 10.
    Williamson LM, Lowe S, Love EM, et al. Serious Hazards of Transfusion (SHOT) Initiative: Analysis of the First Two Annual Reports. BMJ 1999; 319: 16–19.PubMedCrossRefGoogle Scholar
  11. 11.
    Herwaldt B, Persing DH, Precigout EA, et al. A Fatal Case of Babesiosis in Missouri: Identification of Another Piroplasm That Infects Humans. Ann Intern Med 1996; 124: 643–50.PubMedGoogle Scholar
  12. 12.
    Herwaldt BL, Springs FE, Roberts PP, et al. Babesiosis in Wisconsin: a Potentially Fatal Disease. Am J Trop Med Hyg 1995; 53: 146–51.PubMedGoogle Scholar
  13. 13.
    Herwaldt BL, Kjemtrup AM, Conrad PA, et al. Transfusion-Transmitted Babesiosis in Washington State: First Reported Case Caused by a WA1Type Parasite. J Infect Dis 1997; 175: 125962.Google Scholar
  14. 14.
    Babesiosis. Chin J. APHA. Control of communicable diseases. Washington DC, 2000; 17: 62–63. Ref Type: Serial (Book, Monograph).Google Scholar
  15. 15.
    Brasseur P and Gorenflot A. Human Babesiosis in Europe. Mem Inst Oswaldo Cruz 1992; 87 (Suppl 3): 131–32.PubMedCrossRefGoogle Scholar
  16. 16.
    Duh D, Petrovec M, Avsic-Zupanc T. Diversity of Babesia Infecting European Sheep Ticks (Ixodes Ricinus). J Clin Microbiol 2001; 39: 3395–97.PubMedCrossRefGoogle Scholar
  17. 17.
    Saito-Ito A, Tsuji M, Wei Q, et al. Transfusion-Acquired, Autochthonous Human Babesiosis in Japan: Isolation of Babesia Microti-Like Parasites With Hu-RBC-SCID Mice. J Clin Microbiol 2000; 38: 4511–16.PubMedGoogle Scholar
  18. 18.
    Kjemtrup AM and Conrad PA. Human Babesiosis: an Emerging Tick-Borne Disease. Int J Parasitol 2000; 30: 1323–37.PubMedCrossRefGoogle Scholar
  19. 19.
    Gilbert RE. Epidemiology of infection in pregnant women. In: Peterson E, Ambroise-Thomas P. eds. Congenital toxoplasmosis: sientific background, clinical managment and control. Spronger-Verlag, Paris, France. 2000:23749. Type: Serial (Book, Monograph).Google Scholar
  20. 20.
    Buffolano W, Gilbert RE, Holland FJ, Fratta D, Palumbo F, Ades AE. Risk Factors for Recent Toxoplasma Infection in Pregnant Women in Naples. Epidemiol Infect 1996; 116: 347–51.PubMedCrossRefGoogle Scholar
  21. 21.
    Cook AJ, Gilbert RE, Buffolano W, et al. Sources of Toxoplasma Infection in Pregnant Women: European Multicentre Case-Control Study. European Research Network on Congenital Toxoplasmosis. BMJ 2000; 321: 142–47.PubMedCrossRefGoogle Scholar
  22. 22.
    Kapperud G, Jenum PA, Stray-Pedersen B, Melby KK, Eskild A, Eng J. Risk Factors for Toxoplasma Gondii Infection in Pregnancy. Results of a Prospective Case-Control Study in Norway. Am J Epidemiol 1996; 144: 40512.CrossRefGoogle Scholar
  23. 23.
    Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma Gondii: From Animals to Humans. Int J Parasitol 2000; 30: 1217–58.PubMedCrossRefGoogle Scholar
  24. 24.
    Bosch-Driessen EH and Rothova A. Recurrent Ocular Disease in Postnatally Acquired Toxoplasmosis. Am J Ophthalmol 1999; 128: 421–25.PubMedCrossRefGoogle Scholar
  25. 25.
    Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, Rothova A. Ocular Toxoplasmosis: Clinical Features and Prognosis of 154 Patients. Ophthalmology 2002; 109: 869–78.PubMedCrossRefGoogle Scholar
  26. 26.
    Silveira C, Belfort R Jr, Muccioli C, et al. A Follow-Up Study of Toxoplasma Gondii Infection in Southern Brazil. Am J Ophthalmol 2001; 131: 351–54.PubMedCrossRefGoogle Scholar
  27. 27.
    Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO.. Infectious diseases of the fetus and newborn infant. WB Saunders Company 1983:143–263. Ref Type: Serial (Book, Monograph).Google Scholar
  28. 28.
    Koppe JG, Loewer-Sieger DH, Roever-Bonnet H. Results of 20-Year Follow-Up of Congenital Toxoplasmosis. Lancet 1986; 1: 254–56.PubMedCrossRefGoogle Scholar
  29. 29.
    Koppe JG. Prevention of Congenital Toxoplasmosis. Ned TijdschrGeneeskd 1992; 136: 1501–04.Google Scholar
  30. 30.
    Koppe JG and Meenken C. Congenital Toxoplasmosis, Later Relapses and Treatment. Acta Paediatr 1999; 88: 586–88.PubMedCrossRefGoogle Scholar
  31. 31.
    Kupferschmidt O, Kruger D, Held TK, Ellerbrok H, Siegert W, Janitschke K. Quantitative Detection of Toxoplasma Gondii DNA in Human Body Fluids by TaqMan Polymerase Chain Reaction. Clin Microbiol Infect 2001; 7: 120–24.PubMedCrossRefGoogle Scholar
  32. 32.
    Hitt JA and Filice GA. Detection of Toxoplasma Gondii Parasitemia by Gene Amplification, Cell Culture, and Mouse Inoculation. J Clin Microbiol 1992; 30: 3181–84.Google Scholar
  33. 33.
    Das P. Infectious Disease Surveillance Update. Lancet Infect Dis 2002; 2: 203.PubMedCrossRefGoogle Scholar
  34. 34.
    Choi CM and Lerner EA. Leishmaniasis As an Emerging Infection. J Investig Dermatol (Symp.Proc) 2001; 6: 175–82.CrossRefGoogle Scholar
  35. 35.
    Desjeux P. Worldwide Increasing Risk Factors for Leishmaniasis. Med Microbiol Immunol (Berl) 2001; 190: 77–79.Google Scholar
  36. 36.
    Cunningham AC. Parasitic Adaptive Mechanisms in Infection by Leishmania. Exp Mol Pathol 2002; 72: 132–41.PubMedCrossRefGoogle Scholar
  37. 37.
    Gangneux JP and Marty P. Treatment of Visceral Leishmaniasis: Efficacy and Limits of Miltefosine. Sante 2001; 11: 257–58.PubMedGoogle Scholar
  38. 38.
    Osman OF, Oskam L, Zijlstra EE, et al. Evaluation of PCR for Diagnosis of Visceral Leishmaniasis. J Clin Microbiol 1997; 35: 2454–57.PubMedGoogle Scholar
  39. 39.
    Osman OF, Oskam L, Kroon NC, et al. Use of PCR for Diagnosis of PostKala-Azar Dermal Leishmaniasis. J Clin Microbiol 1998; 36: 1621–24.PubMedGoogle Scholar
  40. 40.
    Schonian G, Schweynoch C, Zlateva K, et al. Identification and Determination of the Relationships of Species and Strains Within the Genus Leishmania Using Single Primers in the Polymerase Chain Reaction. Mol Biochem Parasitol 1996; 77: 19–29.PubMedCrossRefGoogle Scholar
  41. 41.
    Le Fichoux Y, Quaranta JF, Aufeuvre JP, et al. Occurrence of Leishmania Infantum Parasitemia in Asymptomatic Blood Donors Living in an Area of Endemicity in Southern France. J Clin Microbiol 1999; 37: 1953–57.PubMedGoogle Scholar
  42. 42.
    Sharma MC, Gupta AK, Das VN, et al. Leishmania Donovani in Blood Smears of Asymptomatic Persons. Acta Trop 2000; 76: 195–96.PubMedCrossRefGoogle Scholar
  43. 43.
    Grogl M, Daugirda JL, Hoover DL, Magill AJ, Berman JD. Survivability and Infectivity of Viscerotropic Leishmania Tropica From Operation Desert Storm Participants in Human Blood Products Maintained Under Blood Bank Conditions. Am J Trop Med Hyg 1993; 49: 308–15.PubMedGoogle Scholar
  44. 44.
    Morales MA, Chicharro C, Ares M, Canavate C, Barker DC, Alvar J. Molecular Tracking of Infections by Leishmania Infantum. Trans R Soc Trop Med Hyg 2001; 95: 104–07.PubMedCrossRefGoogle Scholar
  45. 45.
    Prata A. Clinical and Epidemiological Aspects of Chagas Disease. Lancet Infect Dis 2001; 1: 92–100.PubMedCrossRefGoogle Scholar
  46. 46.
    Wendel S. Current Concepts on Transmission of Bacteria and Parasites by Blood Components. Vox Sang 1994; 67 (Suppl 3): 161–74.PubMedCrossRefGoogle Scholar
  47. 47.
    Urbina JA. Specific Treatment of Chagas Disease: Current Status and New Developments. Curr Opin Infect Dis 2001; 14: 733–41.PubMedCrossRefGoogle Scholar
  48. 48.
    Schmunis GA, Zicker F, Cruz JR, Cuchi P. Safety of Blood Supply for Infectious Diseases in Latin American Countries, 1994–1997. Am J Trop Med Hyg 2001; 65: 924–30.PubMedGoogle Scholar
  49. 49.
    Schmunis GA. Prevention of Transfusional Trypanosoma Cruzi Infection in Latin America. Mem Inst Oswaldo Cruz 1999; 94 (Suppl 1): 93–101.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2002

Authors and Affiliations

  • L. M. Kortbeek
  • E. Pinelli
    • 1
  1. 1.Diagnostic Laboratory for Infectious Diseases and Perinatal ScreeningNational Institute of Public Health and the EnvironmentBilthovenNL

Personalised recommendations